SHABEENA HIRANI: Open Payments
NPI 1841793403 · ELMHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 95 payments from 22 companies in 2025. Trend: 2023 $1,534 · 2024 $2,236 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $394 |
| GENZYME CORPORATION | 7 | $223 |
| Verona Pharma, Inc. | 10 | $222 |
| Regeneron Healthcare Solutions, Inc. | 5 | $177 |
| Actelion Pharmaceuticals US, Inc. | 6 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| Novo Nordisk Inc | 6 | $122 |
| Viatris Specialty LLC | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Amgen Inc. | 4 | $90 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, OPSUMIT, YUPELRI, Ozempic, Cologuard Collection Kit, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
